β-HCG as a Tumor Biomarker with Special Reference to Breast Cancer

Abstract

Introduction Human chorionic gonadotropin (HCG) is a placental protein hormone initially secreted by cells (syncitiotrophoblasts) from the implanting conceptus. It supports the ovarian corpus luteum, endometrial lining and consequently maintains pregnancy [1]. The hormone can be detected in blood and urine, as it is the basis of many pregnancy tests. HCG plays many other roles including stimulating the onset of fetal gonadal steroidogenesis, promotion production of corpus luteal progesterone, immuno-suppression and blockage of phagocytosis of invading trophoblast cells, cytotrophoblast differentiation, growth and differentiation of fetal organs [2]. It is well known that a biomarker is any molecular and chemical changes that can be measured and used to study normal or abnormal process in the body. A tumor marker, like a biomarker, is a naturally occurring substance in the body. A tumor marker can be made by cancer cells or by the body in response to cancer. Tumor markers can provide information that can be used to screen and diagnose cancer as well as identify the stage of cancer to monitor a treatment [3]. It was reported that although mammography, ultrasonography, computed tomography, magnetic resonance imaging scans, and tumor marker assays help in the staging and treatment of cancers, they are usually not definitive diagnostic tests. The diagnosis is mostly confirmed by biopsy [4]. Human chorionic gonadotropin is a glycoprotein composed of 237 amino acids, with α subunit (92 amino acids) and β subunit contains 145 amino acids. It can be used as a tumor marker, as its β subunit is secreted by cell tumor [5]. Breast cancer is the most often diagnosed tumor of women and one of the leading causes of death. The effect of human chorionic gonadotropin on development of cancer is controversial. In fact, for breast cancer there is evidence that this hormone has a protective effect against tumor genesis due the differentiation of the mammary tissue after a full term pregnancy through the down regulation of estrogen receptors. The mechanisms that explain the pro- and anticarcinogenic effects are not fully understood yet [6]. HCG increases uterine arterial blood flow and stimulates angiogenesis in the ovary by stimulating the proliferation of vascular endothelial cells and the expression of vascular endothelial growth factor [7]. It was concluded that high expression of β-HCG is seen more frequently in infiltrative ductal carcinoma with higher grade. There was a high β -HCG expression in high grade tumors of more than 5-cm diameter [8]. The beta subunit of human’s chronic gonadotropin is markedly over expressed by neoplastic cells of differing histological origin including those present in colon, breast, prostate and bladder tumors [9].

Authors and Affiliations

Rafal Al Rawi

Keywords

Related Articles

Can a Nasogastric Tube be Seen As the First Option When Children Intake Peg Prior to Colonoscopy?

According to ESPGHAN, polyethylene glycol with electrolytes (PEG) is generally the recommended laxative for bowel cleansing prior to colonoscopy in children owing to cleansing quality and safety [1]. Children with variou...

Rates of Condom use among HIV Positive Patients on ART in Nasarawa Eggon North Central Nigeria

Introduction: Consistent condom use still remains a key strategy in HIV prevention. Studies have demonstrated declining condom use among HIV positive patients on ART. There is paucity of such information among HIV positi...

Dental Pulp-Derived Stem Cells: A Promising Source for Regenerative Medicine

Regenerative medicine has the potential to replace tissues and organs damaged us-ing stem cells (SCs) and their derivatives. Mesenchymal stromal cells (MSCs) are adult cells, multipotent and funct...

The Scientific Validity of Adverse Events from Schedule of Controlled Substances: C= 100-1/2n

This study provides biological, epidemiological, clinical and mathematical evidence to suggest with % 99.994 certainty that “Schedule of controlled substances“has adverse effects expressed as an equation C=100- 1/2n (wit...

Assessment of Dentists’ Knowledge Concerning the Management of Breastfeeding Patients in Dental Office

Introduction: Breastfeeding is the feeding of babies and young children with milk from a woman’s breast. Breastfeeding has numerous health benefits, including the lower risk for respiratory tract infections, asthma, diar...

Download PDF file
  • EP ID EP569289
  • DOI 10.26717/BJSTR.2017.01.000234
  • Views 165
  • Downloads 0

How To Cite

Rafal Al Rawi (2017). β-HCG as a Tumor Biomarker with Special Reference to Breast Cancer. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(2), 516-517. https://europub.co.uk/articles/-A-569289